The rise of effective weight-loss medications marks a significant shift in chronic weight management. These treatments, including GLP-1 receptor agonists, work by regulating appetite and satiety signals. Typically prescribed alongside lifestyle changes like diet and exercise, they are intended for adults with a BMI over 30, or over 27 with related conditions like hypertension or diabetes.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends